Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?

Many patients with coronavirus disease 2019 (COVID-19) have a hyperactive immune response (cytokine storm) which has been incriminated in multiorgan dysfunction (MOD). Interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are the key cytokines involved in mediating syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Mughal, Mohsin S, Kaur, Ikwinder, Kakadia, Mili, Wang, Chang, Alhashemi, Reem, Salloum, Rafah, Ricca, Anthony, Granet, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815303/
https://www.ncbi.nlm.nih.gov/pubmed/33489621
http://dx.doi.org/10.7759/cureus.12214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815303/
https://www.ncbi.nlm.nih.gov/pubmed/33489621
http://dx.doi.org/10.7759/cureus.12214

Ejemplares similares